When COVID Drug Studies End Up in EMF Research: A Database Reality Check

When COVID Drug Studies End Up in EMF Research: A Database Reality Check

From The Healthier Tech Podcast by Shield Your Body®

May 30, 2026 · 5 min

About this episode

This episode explores a case study of a COVID-19 antiviral drug trial misclassified as EMF research, highlighting issues in research database accuracy.

What happens when a COVID-19 antiviral drug trial gets misclassified as electromagnetic field research? This episode explores a fascinating case study in research database accuracy. I examine how the RECOVERY trial -- which tested molnupiravir and nirmatrelvir-ritonavir in over one thousand COVID patients -- somehow ended up categorized as EMF research. This mix-up reveals important lessons about research integrity, database management, and why careful verification matters in health science. In This Episode The RECOVERY trial's actual findings on COVID antivirals How research databases can go wrong Why proper study categorization matters for health research Featured Study Read the full study: From subsea power cable to small-spotted catshark Scyliorhinus canicula: Behavioural effects of electromagnetic fields in tank experiments See all studies at shieldyourbody.com/research

Topics covered

  • COVID-19
  • antiviral drug trials
  • electromagnetic fields
  • research integrity
  • database management
  • health science

Keywords

  • COVID-19
  • antiviral drugs
  • EMF research
  • research integrity
  • database accuracy
  • health research

Mentioned in this episode

Organizations: RECOVERY trial, shieldyourbody.com

Products: molnupiravir, nirmatrelvir-ritonavir

Books & works: From subsea power cable to small-spotted catshark Scyliorhinus canicula: Behavioural effects of electromagnetic fields in tank experiments

More episodes of The Healthier Tech Podcast

Explore listener stats, chart rankings, contacts and more on the The Healthier Tech Podcast podcast page.